Patrick W Rafter

Title: Innovations of Patrick W Rafter

Introduction

Patrick W Rafter is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to cystic fibrosis. His work has implications for both detection and treatment of this genetic disorder.

Latest Patents

Rafter holds a patent for "Antibodies specific for cystic fibrosis transmembrane conductance." This patent describes antibodies that bind to epitopes of the cystic fibrosis transmembrane conductance regulator (CFTR). The antibodies can be utilized in methods for detecting CFTR in biological samples and for purifying CFTR from impure solutions. Additionally, the invention includes methods for detecting CFTR in biological samples from nonhuman cystic fibrosis knockout animals that have undergone human CFTR replacement therapy. Another aspect of the patent involves determining the orientation of CFTR in the membrane of lipid vesicles. Furthermore, a kit for detecting CFTR in biological samples is also part of this innovative work.

Career Highlights

Patrick W Rafter is associated with Genzyme Corporation, a leading biotechnology company. His role at Genzyme has allowed him to focus on groundbreaking research and development in the field of cystic fibrosis. His contributions have been instrumental in advancing the understanding and treatment of this condition.

Collaborations

Rafter has collaborated with notable colleagues such as Seng H Cheng and John Marshall. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Patrick W Rafter's work exemplifies the impact of innovative research in biotechnology. His patent on antibodies specific for CFTR represents a significant advancement in the detection and treatment of cystic fibrosis. His contributions continue to influence the field and improve the lives of those affected by this condition.